Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines

Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines

Endemic and epidemic group A meningococcal meningitis remains a major cause of morbidity and mortality in sub-Saharan Africa, despite the availability of the safe and inexpensive group A meningococcal polysaccharide vaccine, which is protective at all ages when administered as directed. Despite opti...

Full description

Bibliographic Details
Main Authors: Robbins John B., Schneerson Rachel, Gotschlich Emil C., Mohammed Idris, Nasidi Abdulsalami, Chippaux Jean-Philippe, Bernardino Luis, Maiga Moussa A.
Format: Article
Language:English
Published: The World Health Organization 2003-01-01
Series:Bulletin of the World Health Organization
Subjects:
Meningitis, Meningococcal/epidemiology
Meningitis, Meningococcal/prevention and control
Meningococcal vaccines/pharmacology
Endemic diseases/prevention and control
Mass immunization
Immunization programs
Africa South of the Sahara
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862003001000010

Internet

http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862003001000010

Similar Items